Position in MREO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,867,736
-$183,688 QoQ
Shares Held
15,307,347
0.0% QoQ
Ownership
9.59%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1
of 58 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MREO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. MREO ranks #19 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $216,880,748 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
6,000,000 | $212,340,000 | |
| 3 | ZYME |
Zymeworks Inc.
|
7,000,000 | $182,980,000 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
7,227,778 | $175,345,894 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
9,100,000 | $122,941,000 | |
| 6 | ARDX |
Ardelyx, Inc.
|
16,202,700 | $82,633,770 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
9,339,414 | $78,170,895 | |
| 8 | MNKD |
Mannkind Corp
|
18,000,000 | $76,680,000 |
All Filings in MREO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,867,736 | 15,307,347 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,051,424 | 15,307,347 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,383,163 | 15,307,347 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $31,533,134 | 15,307,347 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41,482,910 | 15,307,347 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,441,530 | 15,307,347 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $53,575,714 | 15,307,347 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $62,913,196 | 15,307,347 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $55,106,449 | 15,307,347 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $44,724,890 | 13,552,997 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $31,307,423 | 13,552,997 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $14,984,794 | 11,616,120 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $15,333,278 | 11,616,120 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,328,846 | 10,366,120 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,774,590 | 10,366,120 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,925,229 | 10,366,120 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,766,854 | 16,756,120 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $16,800,000 | 15,000,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $23,863,115 | 14,914,447 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $27,346,000 | 11,300,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $17,944,127 | 5,660,608 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,823,081 | 2,914,861 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,635,232 | 1,853,417 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||